Loading...
Drägerwerk AG & Co. KGaA
DWRKF•PNK
Healthcare
Medical - Devices
$543.70
$543.70(1.1971920924108106e+42%)

The company's financials show resilient growth, with revenue advancing from $735.82M in Q1 2024 to $774.57M in Q3 2024. Gross profit remained healthy with margins at 44% in Q3 2024 compared to 45% in Q1 2024. Operating income hit $24.008M last quarter, sustaining a consistent 3% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $24.008M. Net income dropped to $14.66M, while earnings per share reached $0.77. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan